For any readers: the MOU is a good step and a strategic research agreement will strengthen competitive advantage, but the tissue cultures are the more important part of this announcement long-term.
Cann Group is standing on Aurora’s shoulders to build their genetic bank, which will put them years ahead of any newcomers in the developing Australian market. This raises the barrier to entry and protects their leading position, so expect strong upward movement on announcement of them passing quarantine in a few months.
For any readers: the MOU is a good step and a strategic research...
Add CAN (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
3.8¢ |
Change
-0.001(2.56%) |
Mkt cap ! $17.74M | |||
| Open | High | Low | Value | Volume |
| 3.9¢ | 3.9¢ | 3.7¢ | $3.023K | 78.56K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 308137 | 3.7¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 3.8¢ | 166529 | 1 |
View Market Depth
| Last trade - 16.10pm 02/08/2024 (20 minute delay) ? |
| CAN (ASX) Chart |